• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 G51D SNCA 突变相关的 α-突触核蛋白病:帕金森病和多系统萎缩之间的联系?

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

机构信息

Queen Square Brain Bank, UCL Institute of Neurology, London, UK.

出版信息

Acta Neuropathol. 2013 May;125(5):753-69. doi: 10.1007/s00401-013-1096-7. Epub 2013 Feb 12.

DOI:10.1007/s00401-013-1096-7
PMID:23404372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3681325/
Abstract

We report a British family with young-onset Parkinson's disease (PD) and a G51D SNCA mutation that segregates with the disease. Family history was consistent with autosomal dominant inheritance as both the father and sister of the proband developed levodopa-responsive parkinsonism with onset in their late thirties. Clinical features show similarity to those seen in families with SNCA triplication and to cases of A53T SNCA mutation. Post-mortem brain examination of the proband revealed atrophy affecting frontal and temporal lobes in addition to the caudate, putamen, globus pallidus and amygdala. There was severe loss of pigmentation in the substantia nigra and pallor of the locus coeruleus. Neuronal loss was most marked in frontal and temporal cortices, hippocampal CA2/3 subregions, substantia nigra, locus coeruleus and dorsal motor nucleus of the vagus. The cellular pathology included widespread and frequent neuronal α-synuclein immunoreactive inclusions of variable morphology and oligodendroglial inclusions similar to the glial cytoplasmic inclusions of multiple system atrophy (MSA). Both inclusion types were ubiquitin and p62 positive and were labelled with phosphorylation-dependent anti-α-synuclein antibodies In addition, TDP-43 immunoreactive inclusions were observed in limbic regions and in the striatum. Together the data show clinical and neuropathological similarities to both the A53T SNCA mutation and multiplication cases. The cellular neuropathological features of this case share some characteristics of both PD and MSA with additional unique striatal and neocortical pathology. Greater understanding of the disease mechanism underlying the G51D mutation could aid in understanding of α-synuclein biology and its impact on disease phenotype.

摘要

我们报告了一个英国家庭,该家庭的帕金森病(PD)患者具有早发性,并且存在 G51D SNCA 突变,该突变与疾病共分离。家族史符合常染色体显性遗传,因为先证者的父亲和姐姐均在三十多岁时出现了对左旋多巴有反应的帕金森病。临床特征与 SNCA 三倍体和 A53T SNCA 突变病例相似。先证者的死后大脑检查显示除了尾状核、壳核、苍白球和杏仁核外,额叶和颞叶也受到影响,出现萎缩。黑质中的色素沉着严重丧失,蓝斑苍白。神经元丢失在额叶和颞叶皮质、海马 CA2/3 亚区、黑质、蓝斑和迷走神经背核中最为明显。细胞病理学包括广泛而频繁的神经元α-突触核蛋白免疫反应性包涵体,形态多样,少突胶质细胞包涵体类似于多系统萎缩(MSA)的胶质细胞质包涵体。两种包涵体类型均为泛素和 p62 阳性,并被磷酸化依赖性抗α-突触核蛋白抗体标记。此外,在边缘区和纹状体中观察到 TDP-43 免疫反应性包涵体。数据显示,该病例的临床和神经病理学与 A53T SNCA 突变和倍增病例均具有相似性。该病例的细胞神经病理学特征与 PD 和 MSA 均具有一些相似性,另外还具有独特的纹状体和新皮质病理学。对 G51D 突变背后的疾病机制的更深入了解,可能有助于理解α-突触核蛋白生物学及其对疾病表型的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/701cbf8051a8/401_2013_1096_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/53248962d740/401_2013_1096_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/9c5c2c99c947/401_2013_1096_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/f6e6ab715c53/401_2013_1096_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/550f0b4d509f/401_2013_1096_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/804ff68b8d3e/401_2013_1096_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/50e91c199c5b/401_2013_1096_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/8b835c9c9c05/401_2013_1096_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/701cbf8051a8/401_2013_1096_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/53248962d740/401_2013_1096_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/9c5c2c99c947/401_2013_1096_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/f6e6ab715c53/401_2013_1096_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/550f0b4d509f/401_2013_1096_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/804ff68b8d3e/401_2013_1096_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/50e91c199c5b/401_2013_1096_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/8b835c9c9c05/401_2013_1096_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/665f/3681325/701cbf8051a8/401_2013_1096_Fig8_HTML.jpg

相似文献

1
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?与 G51D SNCA 突变相关的 α-突触核蛋白病:帕金森病和多系统萎缩之间的联系?
Acta Neuropathol. 2013 May;125(5):753-69. doi: 10.1007/s00401-013-1096-7. Epub 2013 Feb 12.
2
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.与α-突触核蛋白(SNCA)重复及H50Q突变相比,G51D SNCA突变病例的独特临床和神经病理学特征。
Mol Neurodegener. 2015 Aug 27;10:41. doi: 10.1186/s13024-015-0038-3.
3
Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology.与非典型多系统萎缩和帕金森病型病理相关的新型α-突触核蛋白突变A53E
Neurobiol Aging. 2014 Sep;35(9):2180.e1-5. doi: 10.1016/j.neurobiolaging.2014.03.024. Epub 2014 Mar 26.
4
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.G51D SNCA 突变在早发性帕金森病中产生一种缓慢进展的 α-突触核蛋白菌株。
Acta Neuropathol Commun. 2023 May 3;11(1):72. doi: 10.1186/s40478-023-01570-5.
5
Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson's disease.伴有 A53T 突变的α-突触核蛋白病和家族性帕金森病患者的病理学发现。
Parkinsonism Relat Disord. 2020 Dec;81:183-187. doi: 10.1016/j.parkreldis.2020.11.001. Epub 2020 Nov 4.
6
Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.A53Tα-突触核蛋白帕金森病运动前期和运动期的血清素能病理学和疾病负担:一项横断面研究。
Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19.
7
123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.123I-FP-CIT SPECT(123 碘-2β- 碳甲氧基-3β-(4- 碘苯基)-N-(3- 氟丙基)去甲托烷单光子发射计算机断层扫描)成像在帕金森病患者与帕金森病患者的 p.A53T α- 突触核蛋白帕金森病队列中的应用。
Mov Disord. 2018 Nov;33(11):1734-1739. doi: 10.1002/mds.27451. Epub 2018 Oct 4.
8
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
9
Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.使用靶向 SNCA 分析和单细胞测序技术研究突触核蛋白病患者大脑中的体细胞核型变异。
Acta Neuropathol Commun. 2019 Dec 23;7(1):219. doi: 10.1186/s40478-019-0873-5.
10
Generation of TWO G51D SNCA missense mutation iPSC lines (CRICKi011-A, CRICKi012-A) from two individuals at risk of Parkinson's disease.从两名帕金森病风险个体中生成的两个 G51D SNCA 错义突变 iPSC 系(CRICKi011-A,CRICKi012-A)。
Stem Cell Res. 2023 Sep;71:103134. doi: 10.1016/j.scr.2023.103134. Epub 2023 Jun 6.

引用本文的文献

1
MicroRNAs and synaptic dysfunction in Parkinson's disease.帕金森病中的微小RNA与突触功能障碍
Mol Ther Nucleic Acids. 2025 Aug 12;36(3):102673. doi: 10.1016/j.omtn.2025.102673. eCollection 2025 Sep 9.
2
Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation.α-突触核蛋白C末端截短在病理学及路易小体形成中的不同作用
NPJ Parkinsons Dis. 2025 Aug 26;11(1):261. doi: 10.1038/s41531-025-01084-y.
3
Evidence of a novel α-synuclein strain isolated from a Parkinson's disease with dementia patient sample.

本文引用的文献

1
A novel α-synuclein missense mutation in Parkinson disease.一种新型α-突触核蛋白错义突变与帕金森病。
Neurology. 2013 Mar 12;80(11):1062-4. doi: 10.1212/WNL.0b013e31828727ba. Epub 2013 Feb 20.
2
Elucidating the role of C-terminal post-translational modifications using protein semisynthesis strategies: α-synuclein phosphorylation at tyrosine 125.利用蛋白质半合成策略阐明 C 末端翻译后修饰的作用:酪氨酸 125 处的α-突触核蛋白磷酸化。
J Am Chem Soc. 2012 Mar 21;134(11):5196-210. doi: 10.1021/ja210866j. Epub 2012 Mar 13.
3
Mutant protein A30P α-synuclein adopts wild-type fibril structure, despite slower fibrillation kinetics.
从一名帕金森病合并痴呆患者样本中分离出新型α-突触核蛋白毒株的证据。
Acta Neuropathol Commun. 2025 Aug 18;13(1):177. doi: 10.1186/s40478-025-02093-x.
4
Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.在一种新型人源化大鼠模型中,缺乏内源性大鼠α-突触核蛋白的情况下,人A53Tα-突触核蛋白的表达未能引发帕金森病相关表型。
PLoS One. 2025 Aug 8;20(8):e0329823. doi: 10.1371/journal.pone.0329823. eCollection 2025.
5
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.帕金森病中的认知衰退:从临床表型到遗传背景
Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624.
6
Autonomic dysfunction in multiple system atrophy: from pathophysiology to clinical manifestations.多系统萎缩中的自主神经功能障碍:从病理生理学到临床表现
Ann Med. 2025 Dec;57(1):2488111. doi: 10.1080/07853890.2025.2488111. Epub 2025 Apr 8.
7
The Yeast Parkinson's Disease Model Exhibits An Increase in Peroxisome Number Independent of the Division Proteins Vps1 and Dnm1.酵母帕金森病模型显示过氧化物酶体数量增加,且与分裂蛋白Vps1和Dnm1无关。
Mol Neurobiol. 2025 Jul 24. doi: 10.1007/s12035-025-05236-2.
8
Glycine-to-aspartic acid mutation at codon 51 in disrupts the synaptic localisation of α-synuclein and enhances its propensity for synucleinopathy.第51密码子处甘氨酸到天冬氨酸的突变破坏了α-突触核蛋白的突触定位,并增强了其发生突触核蛋白病的倾向。
Brain Commun. 2025 Jun 6;7(3):fcaf224. doi: 10.1093/braincomms/fcaf224. eCollection 2025.
9
α-Synuclein Pathology Spreads in a Midbrain-Hindbrain Assembloid Model.α-突触核蛋白病理学在中脑-后脑类器官模型中扩散。
Adv Sci (Weinh). 2025 May;12(20):e2409040. doi: 10.1002/advs.202409040. Epub 2025 Apr 17.
10
Identical Seeding Characteristics and Cryo-EM Filament Structures in FTLD-Synuclein and Typical Multiple System Atrophy.额颞叶痴呆-突触核蛋白病和典型多系统萎缩中的相同播种特征及冷冻电镜丝状结构
Neuropathol Appl Neurobiol. 2025 Apr;51(2):e70013. doi: 10.1111/nan.70013.
突变蛋白 A30P α-突触核蛋白采用野生型纤维结构,尽管纤维形成动力学较慢。
J Biol Chem. 2012 Mar 30;287(14):11526-32. doi: 10.1074/jbc.M111.306902. Epub 2012 Feb 9.
4
Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.散发性帕金森病的神经病理学:评估和概念变化。
Mov Disord. 2012 Jan;27(1):8-30. doi: 10.1002/mds.23795. Epub 2011 Nov 11.
5
The neuropathology, pathophysiology and genetics of multiple system atrophy.多系统萎缩的神经病理学、病理生理学和遗传学。
Neuropathol Appl Neurobiol. 2012 Feb;38(1):4-24. doi: 10.1111/j.1365-2990.2011.01234.x.
6
Parkinson's disease and α-synuclein expression.帕金森病与α-突触核蛋白表达。
Mov Disord. 2011 Oct;26(12):2160-8. doi: 10.1002/mds.23948. Epub 2011 Sep 1.
7
Neuropathology underlying clinical variability in patients with synucleinopathies.突触核蛋白病患者临床变异性的神经病理学基础。
Acta Neuropathol. 2011 Aug;122(2):187-204. doi: 10.1007/s00401-011-0852-9. Epub 2011 Jul 1.
8
Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals.苍白的神经突,α-突触核蛋白过早聚集,并从轴突侧支呈向心性延伸。
Brain Pathol. 2012 Jan;22(1):67-78. doi: 10.1111/j.1750-3639.2011.00509.x. Epub 2011 Aug 16.
9
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?路易体和阿尔茨海默病病理学在帕金森病痴呆中的作用:哪个更重要?
Brain. 2011 May;134(Pt 5):1493-1505. doi: 10.1093/brain/awr031.
10
Preparation and characterization of neurotoxic tau oligomers.神经毒性 tau 寡聚物的制备与表征。
Biochemistry. 2010 Nov 30;49(47):10039-41. doi: 10.1021/bi1016233. Epub 2010 Nov 8.